Protocol Effect of Negative Pressure Drain to Reducing Surgical Site Infection in Surgical Wound of Abdominal Surgery - Trial NCT05865821
Access comprehensive clinical trial information for NCT05865821 through Pure Global AI's free database. This phase not specified trial is sponsored by Mahidol University and is currently Enrolling by invitation. The study focuses on Surgical Site Infection. Target enrollment is 130 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Mahidol University
Timeline & Enrollment
N/A
Apr 15, 2023
Mar 30, 2025
Primary Outcome
Rate of SSI,Rate of SSI,Rate of SSI,Rate of SSI
Summary
Surgical site infection (SSI) is one of main complication in surgery. It usually occurs
 within 30 days post operation. The superficial SSI is an infection of skin and subcutaneous
 layer, clinically presented by pus oozing. Furthermore, seroma hematoma and wound dehiscence
 are also clinical signs of superficial SSI.
 
 Nowadays, there are studies which report methods reducing SSI by placing negative pressure
 drain within surgical wound. It can reduce serum in subcutaneous layer which is found in
 every surgical wound, especially in clean-contaminated and contaminated wound. Many studies
 show that placing negative pressure drainage within a surgical wound can reduce superficial
 SSI and decrease hospital length of stay by comparing with the control group.
 
 The objective in this study to compare the rate of SSI of clean-contaminated and contaminated
 surgical wounds between the patients whose wounds are placed with negative pressure drainage
 and patients who were not placed with negative pressure drainage.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05865821
Non-Device Trial